Lpl Financial LLC Eli Lilly & CO Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

A detailed history of Lpl Financial LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lpl Financial LLC holds 849,853 shares of LLY stock, worth $746 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

849,853

Previous 756,829 12.29%

Holding current value

$746 Million

Previous $589 Million 30.68%

% of portfolio

0.39%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $67.4 Million - $84.6 Million	93,024 Added 12.29%	849,853 $769 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $42.1 Million - $56.3 Million	71,046 Added 10.36%	756,829 $589 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $47.5 Million - $56 Million	90,396 Added 15.18%	685,783 $400 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $44.7 Million - $61.6 Million	102,734 Added 20.85%	595,387 $320 Million
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $23.4 Million - $31.3 Million	66,682 Added 15.65%	492,653 $231 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $3.3 Million - $3.88 Million	10,636 Added 2.56%	425,971 $146 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $12.4 Million - $14.5 Million	38,686 Added 10.27%	415,335 $152 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $7.8 Million - $8.89 Million	26,307 Added 7.51%	376,649 $122 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $8.55 Million - $10 Million	30,673 Added 9.6%	350,342 $114 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $3.67 Million - $4.56 Million	15,642 Added 5.14%	319,669 $91.5 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $4.51 Million - $5.59 Million	20,048 Added 7.06%	304,027 $84 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.01 Million - $2.47 Million	9,069 Added 3.3%	283,979 $65.6 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $5.92 Million - $7.66 Million	32,810 Added 13.55%	274,910 $63.1 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $631,810 - $817,908	3,845 Added 1.61%	242,100 $45.2 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $3.11 Million - $4.12 Million	23,838 Added 11.12%	238,255 $40.2 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $606,666 - $701,720	4,149 Added 1.97%	214,417 $31.7 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $1.48 Million - $1.78 Million	10,860 Added 5.45%	210,268 $34.5 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $1.45 Million - $1.79 Million	12,162 Added 6.5%	199,408 $27.7 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $1.37 Million - $1.69 Million	12,782 Added 7.33%	187,246 $24.6 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $1.02 Million - $1.1 Million	-9,507 Reduced 5.17%	174,464 $19.5 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $3.49 Million - $4.08 Million	-31,534 Reduced 14.63%	183,971 $20.4 Million
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $1.63 Million - $1.92 Million	14,645 Added 7.29%	215,505 $28 Million
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $3.43 Million - $3.84 Million	32,381 Added 19.22%	200,860 $23.2 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $736,077 - $919,968	8,573 Added 5.36%	168,479 $18.1 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $479,332 - $550,124	-6,332 Reduced 3.81%	159,906 $13.6 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $2.86 Million - $3.38 Million	-38,571 Reduced 18.83%	166,238 $12.9 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $2.69 Million - $2.88 Million	32,794 Added 19.06%	204,809 $17.3 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $409,241 - $454,217	-5,310 Reduced 2.99%	172,015 $14.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	177,325	177,325 $14.6 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Eli Lilly & CO Transaction History